Corticobasal syndrome (CBS) is a clinical syndrome determined by various underlying neurodegenerative disorders requiring a pathological assessment for a definitive diagnosis. A literature review was performed following the methodology described in the Cochrane Handbook for Systematic Reviews to investigate the additional value of traditional and cutting-edge cerebrospinal fluid (CSF) and serum/plasma biomarkers in profiling CBS. Four databases were screened applying predefined inclusion criteria: (1) recruiting patients with CBS; (2) analyzing CSF/plasma biomarkers in CBS. The review highlights the potential role of the association of fluid biomarkers in diagnostic workup of CBS, since they may contribute to a more accurate diagnosis and patient selection for future disease-modifying agent; for example, future trial designs should consider baseline CSF Neurofilament Light Chains (NfL) or progranulin dosage to stratify treatment arms according to neuropathological substrates, and serum NfL dosage might be used to monitor the evolution of CBS. In this scenario, prospective cohort studies, starting with neurological examination and neuropsychological tests, should be considered to assess the correlations of clinical profiles and various biomarkers.

Remoli, G., Schilke, E., Magi, A., Ancidoni, A., Negro, G., Da Re, F., et al. (2024). Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review. NEUROLOGICAL RESEARCH AND PRACTICE, 6(1) [10.1186/s42466-023-00294-0].

Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review

Remoli, Giulia;Schilke, Edoardo Dalmato
;
Magi, Andrea;Negro, Giulia;Da Re, Fulvio;Frigo, Maura;Ferrarese, Carlo;Tremolizzo, Lucio;Appollonio, Ildebrando
2024

Abstract

Corticobasal syndrome (CBS) is a clinical syndrome determined by various underlying neurodegenerative disorders requiring a pathological assessment for a definitive diagnosis. A literature review was performed following the methodology described in the Cochrane Handbook for Systematic Reviews to investigate the additional value of traditional and cutting-edge cerebrospinal fluid (CSF) and serum/plasma biomarkers in profiling CBS. Four databases were screened applying predefined inclusion criteria: (1) recruiting patients with CBS; (2) analyzing CSF/plasma biomarkers in CBS. The review highlights the potential role of the association of fluid biomarkers in diagnostic workup of CBS, since they may contribute to a more accurate diagnosis and patient selection for future disease-modifying agent; for example, future trial designs should consider baseline CSF Neurofilament Light Chains (NfL) or progranulin dosage to stratify treatment arms according to neuropathological substrates, and serum NfL dosage might be used to monitor the evolution of CBS. In this scenario, prospective cohort studies, starting with neurological examination and neuropsychological tests, should be considered to assess the correlations of clinical profiles and various biomarkers.
Articolo in rivista - Review Essay
CBS biomarkers; CBS neuropathology; Corticobasal syndrome; Dementia biomarkers; Fluid biomarkers;
English
4-gen-2024
2024
6
1
1
open
Remoli, G., Schilke, E., Magi, A., Ancidoni, A., Negro, G., Da Re, F., et al. (2024). Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review. NEUROLOGICAL RESEARCH AND PRACTICE, 6(1) [10.1186/s42466-023-00294-0].
File in questo prodotto:
File Dimensione Formato  
10281-455818_VoR.pdf

accesso aperto

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Licenza: Creative Commons
Dimensione 1.36 MB
Formato Adobe PDF
1.36 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/455818
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact